Literature DB >> 28716377

Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery.

D Zhang1, Y Zheng2, Z Wang2, Q Huang3, X Cao4, F Wang1, S Liu5.   

Abstract

BACKGROUND: Recently, the 8th edition of the TNM classification of esophageal cancer has come up. The present study aims to compare the 7th and the proposed 8th edition of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma (ESCC).
METHODS: A total of 1872 ESCC patients who underwent radical surgery with curative intent were analyzed retrospectively. Survival was analyzed using the Kaplan-Meier method, and values were compared using the log-rank test. Multivariate analysis was performed using the Cox proportional hazard model. The Akaike information criterion (AIC) and the concordance index (c-index) were applied to compare the two prognostic systems.
RESULTS: On univariate analysis, the 7th staging system, the proposed 8th staging system, gender, age as well as adjuvant treatment were found to have significant association with overall survival (OS). In both the current staging system and the modified version, age and gender were independent prognostic factors in a multivariate analysis. The AIC value for the proposed 8th version was smaller than that for the 7th staging system; the c-index value for the proposed 8th version was larger than that for the 7th staging system. Subgroup analysis in patients with/without nodal metastasis obtained consistent results.
CONCLUSION: Based on the data from our single center, the proposed 8th AJCC staging system seems to be superior to the 7th AJCC staging system in terms of OS for patients with thoracic ESCC who underwent radical surgery.
Copyright © 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Prognosis; Squamous cell carcinoma

Mesh:

Year:  2017        PMID: 28716377     DOI: 10.1016/j.ejso.2017.06.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  19 in total

1.  Negative lymph node at station 108 is a strong predictor of overall survival in esophageal cancer.

Authors:  Jinling Zhang; Xueyuan Heng; Yi Luo; Luning Li; Haiyan Zhang; Fengyuan Che; Baosheng Li
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

2.  Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy.

Authors:  Masahiro Inada; Yasumasa Nishimura; Kazuki Ishikawa; Kiyoshi Nakamatsu; Yutaro Wada; Takuya Uehara; Kohei Fukuda; Shimpei Anami; Hiroshi Doi; Shuichi Kanamori
Journal:  Esophagus       Date:  2019-05-20       Impact factor: 4.230

3.  Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.

Authors:  Shuning Ding; Jiayi Wu; Caijin Lin; Lisa Andriani; Chihwan Goh; Weiguo Chen; Yafen Li; Kunwei Shen; Li Zhu
Journal:  Oncologist       Date:  2019-04-24

4.  Predicting prognosis for patients with ESCC before surgery by SVMs ranking with nomogram analyses.

Authors:  Zhi Sheng Jiang; Meng Qing Xu; Zhuang Zhuang Cong; Li Wen Hu; Jing Luo; Yi Fei Diao; Yi Shen
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

5.  Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System.

Authors:  Hyunjong Lee; Kyung Soo Lee; Yang Won Min; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim; Joon Young Choi
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

6.  Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.

Authors:  Mitsuro Kanda; Yun-Suhk Suh; Do Joong Park; Chie Tanaka; Sang-Hoon Ahn; Seong-Ho Kong; Hyuk-Joon Lee; Daisuke Kobayashi; Michitaka Fujiwara; Hideaki Shimada; BeLong Cho; Kenta Murotani; Hyung-Ho Kim; Han-Kwang Yang; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2019-08-03       Impact factor: 7.370

7.  Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma.

Authors:  Natsuru Sudo; Hiroshi Ichikawa; Yusuke Muneoka; Takaaki Hanyu; Yosuke Kano; Takashi Ishikawa; Yuki Hirose; Kohei Miura; Yoshifumi Shimada; Masayuki Nagahashi; Jun Sakata; Takashi Kobayashi; Takeo Bamba; Satoru Nakagawa; Shin-Ichi Kosugi; Toshifumi Wakai
Journal:  Ann Surg Oncol       Date:  2020-10-06       Impact factor: 5.344

8.  [Effects of minimally invasive versus open esophagectomy on circulating tumor cells in patients with esophageal cancer].

Authors:  Xin Guo; Yuan-Zhou Wu; Long-Fei Jia; Ya-Ling Li; Yu-Sheng Yan; Qun-Qing Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-03-20

9.  Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8th edition of the TNM staging system for esophageal cancer?

Authors:  Ran Mo; Chen Chen; Liang Pan; Ao Yu; Dongjin Wang; Tao Wang
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

10.  Proposal for a New TNM Stage based on the 7th and 8th American Joint Committee on Cancer pTNM Staging Classification for Gastric Cancer.

Authors:  Miao-Zhen Qiu; Zi-Xian Wang; Yi-Xin Zhou; Da-Jun Yang; Feng-Hua Wang; Rui-Hua Xu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.